Migraine Clinical Trials in Phoenix

Showing 21-40 of 107 trials

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

NCT06401642

Zavegepant (Zavzpret) is approved for the acute treatment of migraine with or without aura in the US. The purpose of this study is to investigate the effectiveness and tolerability of zavegepant for the acute treatment of migraine attacks amongst participants who are using calcitonin gene-related peptide (CGRP) migraine preventive treatments.

Migraine

Mayo Clinic200 participantsStarted Mar 2024

Phoenix, Arizona, United States

COMPLETEDPhase 4< 1 mile

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

NCT05207865

The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.

MigraineEpisodic MigrainePhonophobia+1 more

Pfizer441 participantsStarted Mar 2022

Phoenix, Arizona, United States • Hawthorne, California, United States • North Hollywood, California, United States +16 more locations

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Migraine Trials in Other Cities

A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Eptinezumab in Participants With Episodic Cluster Headache

A Study of LY3451838 in Participants With Migraine

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

A Study of Remote Electrical Neuromodulation for Acute Procedural Pain

Imaging the Migraine Brain Pre- and Post-Erenumab

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

PArtial REbreathing for Migraine With Aura 1

Alleviation of Common Cold Symptoms

Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

Other Conditions in Phoenix